Picture of 3i logo

III 3i News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedLarge CapNeutral

REG - 3i Group PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240605:nRSE3105Ra&default-theme=true

RNS Number : 3105R  3i Group PLC  05 June 2024

Market Abuse Regulation

 

MAR Article 19

 

On 5 June 2024, 3i Group plc (the "Company") was notified of the following.

 

On 4 June 2024 the persons discharging material responsibilities ("PDMRs")
named in the table below acquired for nil cost ordinary shares of 73 19/22p
each (ISIN: GB00B1YW4409) in the Company ("Shares") on the release of share
awards under the 3i Special Share Award Plan. On that date the Shares shown in
the column headed "Shares acquired" ceased to be subject to restrictions under
the Plan. The Shares (if any) shown in the column headed "Shares sold" were
sold on the same date at a price of £29.312904 per share.

 

 PDMR          Shares acquired  Shares sold
 S Moseley     88,566           41,689
 B Sottomayor  88,566           88,566

 

On 4 June 2024 share awards under 3i Group Discretionary Share Plan (the
"Plan") held by the persons discharging managerial responsibilities ("PDMRs")
named in the table below vested.  On that date the Shares shown in the column
headed "Shares acquired" ceased to be subject to restrictions under the
Plan.  The Shares (if any) shown in the column headed "Shares sold" were sold
on the same date at a price of £29.312904 per share.

 

 PDMR        Shares acquired  Shares sold
 K J Dunn    15,659           7,378
 J H Halai   7,339            3,460
 J Hatchley  10,912           5,143
 J Marie     6,920            3,263

 

The place of these transactions was the London Stock Exchange.

 

Ends

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUPUUUQUPCGMA

Recent news on 3i

See all news